Issue #101: Investigation of the potential mechanism by which methylparaben induces psoriasis: an integrated study using network toxicology, molecular docking, molecular dynamics simulation, and eight machine learning algorithms.
Protein Design Digest #101: Investigation of the potential mechanism by which methylparaben induces …

Building something in Protein Design?
I love collaborating on new challenges. Let's build together.
Subscribe to Protein Design Digest
Daily curated signals from arXiv, PubMed, and BioRxiv.
Signal of the Day
Investigation of the potential mechanism by which methylparaben induces psoriasis: an integrated study using network toxicology, molecular docking, molecular dynamics simulation, and eight machine learning algorithms.
Psoriasis is a chronic inflammatory skin disease with limited safe and effective treatments. Methylparaben, a widely used preservative in cosmetics, pharmaceuticals, and food, is an emerging environmental pollutant linked to immune-related skin disorders, but its role and mechanism in psoriasis remain unclear. This study explored its potential mechanism using network toxicology, molecular docking, molecular dynamics simulation, and eight machine learning algorithms. Methylparaben targets were retrieved from GeneCards and TCMSP, and psoriasis-related targets from CTD and GeneCards. Overlapping targets were screened with Venny 2.1.0. A PPI network was constructed via STRING, and core targets identified using Cytoscape 3.10.2. GO and KEGG enrichment analyses were performed on DAVID. Molecular docking evaluated the binding affinity of methylparaben with key targets. A total of 138 compound-related and 5,592 psoriasis-related targets were identified. Core targets such as INS, HIF1A, and PPARG are involved in regulating immune-inflammatory responses, keratinocyte proliferation and differentiation, and oxidative stress. GO analysis revealed enrichment in xenobiotic metabolism, lipopolysaccharide response, and metal ion binding. KEGG analysis highlighted pathways related to cancer, chemical carcinogenesis from reactive oxygen species, and drug metabolism via cytochrome P450 enzymes. Molecular docking showed stable binding of methylparaben to INS (-4.5 kcal/mol), HIF1A (-5.9 kcal/mol), and PPARG (-5.5 kcal/mol), primarily through hydrogen bonds and hydrophobic interactions. Methylparaben may exert its effects on psoriasis via multi-target and multi-pathway mechanisms, influencing inflammation, oxidative stress, and cellular regulation. These findings provide valuable insight into its toxicological mechanism and potential therapeutic application.
Why this matters: Provides actionable mutations to enhance catalytic efficiency or thermostability.
Also Worth Reading
Do Larger Models Really Win in Drug Discovery? A Benchmark Assessment of Model Scaling in AI-Driven Molecular Property and Activity Prediction
The rapid growth of molecular foundation models and general-purpose large language models has encouraged a scale-centric view of artificial intelligence in drug discovery, in which larger pretrained models are expected to supersede compact cheminformatics models and task-specific graph neural networks (GNNs). We test this assumption on 22 molecular property and activity endpoints, including public ADMET and Tox21 benchmarks and two internal anti-infective activity datasets. Across 167,056 held-out task–molecule evaluations under structure-similarity-separated five-fold cross-validation (37,756 ADMET, 77,946 Tox21, 49,266 anti-TB and 2,088 antimalaria), classical machine-learning (ML) models such as RF(ECFP4) and ExtraTrees(RDKit descriptors) win ten primary-metric tasks, GNNs such as GIN and Ligandformer win nine, and pretrained molecular sequence models such as MoLFormer and ChemBERTa2 win three. Rule-based SAR reasoning baselines, represented by GPT5.5-SAR and Opus4.7-SAR, do not win under the prespecified primary metrics, although train-fold-derived SAR knowledge provides measurable but uneven gains for SAR reasoning and interpretation. These results indicate that compact, specialized models remain highly effective for molecular property and activity prediction. The performance differences among classical ML, GNN and pretrained sequence models are often modest and endpoint-dependent, whereas larger or more general models do not provide a universal predictive advantage. Large models may still add value for zero-shot reasoning, SAR interpretation and hypothesis generation, but the results suggest that predictive performance depends on the alignment among molecular representation, inductive bias, data regime, endpoint biology and validation protocol.
Identification of paucinervin D as a natural sphingosine-1-phosphate receptor 1 agonist: Insights from pharmacophore modeling, docking, molecular dynamics simulations, and density functional theory.
Sphingosine-1-phosphate receptor 1 (S1PR1), a member of the G protein-coupled receptor (GPCR) family, is a crucial therapeutic target for various diseases. Activation of S1PR1 has been recognized as an effective therapeutic strategy for multiple sclerosis (MS), inflammatory bowel disease (IBD), and psoriasis. Natural products (NPs) serve as a rich source of bioactive compounds for drug discovery. Here, we aimed to discover novel S1PR1 agonists from NPs via multi-level virtual screening (VS). Using a validated HipHop pharmacophore model, we screened a database containing 54,642 NPs, followed by molecular docking. Based on binding mode analysis, four candidate S1PR1 agonists (NPC323626, NPC264112, NPC469907, and NPC22192) were selected. Subsequent molecular dynamics (MD) simulations and binding free energy calculations confirmed the stability of the receptor-ligand complexes and their binding affinities. Among the four candidates, NPC469907 exhibited the strongest binding affinity for S1PR1, with a value of -58.08 ± 0.13 kJ/mol. Furthermore, hydrogen bonds formed between NPC469907 and Glu121 of S1PR1 were found to be essential for receptor activation. Quantum mechanical calculations further revealed that the phenyl-ring-attached hydrogen site in NPC469907 could be modified without compromising its ability to activate S1PR1. The analysis of Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) indicated that NPC469907 possessed favorable pharmacokinetic properties and low toxicity. In conclusion, our study identified NPC469907 as a promising natural S1PR1 agonist and established an effective VS strategy for the discovery of novel S1PR1 agonists.
Natural compounds extracted from medicinal herbs in the treatment of Parkinson’s disease; Molecular Docking, Molecular Dynamics simulation, and Quantum Mechanical calculations.
The dopamine D3 receptor (D3R), which belongs to class A of G-protein-coupled receptors (GPCRs), is a promising target and is significantly involved in the pathology of Parkinson’s disease progression. This study examines the inhibitory effects of natural compounds on D3R, highlighting their potential therapeutic applications in mitigating disease progression. Molecular docking simulations were conducted using AutoDock4.2, MOE, ICM, and Vina to evaluate the binding affinity of selected phytochemicals relative to levodopa (compound 1), a standard dopaminergic drug. Compounds such as 5, 13, and 15 demonstrated superior docking scores compared to compound 1. The ADMET analyses revealed favorable bioavailability and drug-likeness profiles, especially for 5, 13, and 15 compounds. Additionally, the stability of the 5_D3R and 13_D3R complexes relative to the 1_D3R complex was confirmed through a molecular dynamics (MD) simulation, which supports the biological potential of polygoni and green tea. According to the binding free energy calculated using MMPB(GB)SA, 5_D3R and 13_D3R complexes exhibit greater stability, which is in agreement with the MD simulation. Finally, a rigorous three-layer ONIOM (M06-2X/6-31G∗:PM6:AMBER) analysis confirmed that compounds 5 and 13 effectively inhibit D3R, highlighting their potential as promising drug candidates.
Research & AI Updates
- BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026 - The Manila Times — BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026 The Manila Times.
- Plants Walk Fine Line Between Growth And Defense - Mirage News — Plants Walk Fine Line Between Growth And Defense Mirage News.
- VUStruct enables high-throughput personalized structural biology - Let’s Data Science — VUStruct enables high-throughput personalized structural biology Let’s Data Science.
- IBM’s MAMMAL Is a Quiet Demonstration That Biomedical AI Is Moving Beyond Single-Purpose Models - Startup Fortune — IBM’s MAMMAL Is a Quiet Demonstration That Biomedical AI Is Moving Beyond Single-Purpose Models Startup Fortune.
- Armata Pharmaceuticals Announces Structural Biology Publication in “Communications Biology” - PR Newswire — Armata Pharmaceuticals Announces Structural Biology Publication in “Communications Biology” PR Newswire.
From the Industry
- IPO Tracker 2026: Odyssey eyes $236M for renewed Nasdaq bid, Seaport docks on Nasdaq - BioSpace — IPO Tracker 2026: Odyssey eyes $236M for renewed Nasdaq bid, Seaport docks on Nasdaq BioSpace.
- Biotech firm Odyssey targets $810 million valuation in US IPO - Reuters — Biotech firm Odyssey targets $810 million valuation in US IPO Reuters.
- New TMC partnership aims to grow Houston’s biomanufacturing workforce - InnovationMap — New TMC partnership aims to grow Houston’s biomanufacturing workforce InnovationMap.
- Oak Creek-Franklin Joint School District Announces Strategic Partnership with Edustaff to Strengthen Educator Staffing Solutions - The Manila Times — Oak Creek-Franklin Joint School District Announces Strategic Partnership with Edustaff to Strengthen Educator Staffing Solutions The Manila Times.
- Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate - BioSpace — Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate BioSpace.
- Generative AI is building drugs faster than systems can regulate them - Devdiscourse — Generative AI is building drugs faster than systems can regulate them Devdiscourse.
- Genetically modified organism - Medicine, Research, Biotechnology - Britannica — Genetically modified organism - Medicine, Research, Biotechnology Britannica.
Quick Reads
Integrated Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and In Vitro Validation Reveal the Mechanism of Astragalus Root Against Diabetic Nephropathy
Background: /Objectives: Astragalus root, a traditional Chinese herbal remedy, has shown potential benefits against diabetic nephropathy (DN). Read more →
Computational insights into Ru(II)-coumarin complexes as potential anticancer agents: a DFT, QTAIM, NCI-RDG, molecular docking and molecular dynamics approach.
Ru(II) complexes have been explored as promising candidates for novel anticancer agents, due to their significant bioactivity, selective cytotoxicity, and ability to induce apoptosis via multiple signalling pathways, with coumarin derivatives serving as effective ligands to enhance their therapeutic efficacy. Read more →
XL-MS and De Novo Protein Design Identified a Common Motif for TREM2 Binding.
Apolipoprotein E ( APOE ) and Triggering Receptor Expressed on Myeloid cells 2 ( TREM2 ) are the two strongest genetic risk factors of late-onset Alzheimer’s disease. Read more →
Proteome-wide reverse molecular docking reveals folic acid receptor as a mediator of PFAS-induced neurodevelopmental toxicity
Per- and polyfluoroalkyl substances (PFAS) are a class of long-lasting chemicals with widespread use and environmental persistence that have been increasingly studied for their detrimental impacts to human and animal health. Read more →
New benzochromene-based compounds as potential EGFR-TK inhibitors: synthesis, anti-proliferative activity, molecular docking studies, and ADME profiles.
In this study, we report the synthesis and biological evaluation of a novel series of benzochromene and benzochromenopyrimidine derivatives employingenaminonitrile compound 1 as a key synthetic precursor. Read more →
Synthesis and Evaluation of Isatin Analogs as Potential Urease and Tyrosinase Inhibitors: An Approach of Molecular Docking.
A series of isatin-based Schiff base derivatives (1-12) was synthesized via a two-step reaction and characterized using spectroscopic techniques such as 1H-NMR and mass spectrometry. Read more →
Unveiling the nectar-like aroma in sauce-flavor baijiu: From molecular sensory science to molecular docking.
The nectar-like aroma is a crucial sensory attribute of sauce-flavor Baijiu (SFB). Read more →
Integrating Machine Learning Interatomic Potentials with MMPBSA for Accurate Protein-Ligand Binding Free Energy Calculations.
End-point binding free energy (BFE) methods, such as molecular mechanics Poisson-Boltzmann surface area (MMPBSA), are widely used to estimate protein-ligand binding affinity due to their favorable balance between accuracy and computational efficiency. Read more →
Pipeline Tip
Use local MSA generation (colabfold_search) to bypass speed bottlenecks.
Resources & Tools
- Dataset: BFD - Big Fantastic Database for deep learning protein modeling.
- Dataset: MGnify - Metagenomics resource for microbiome sequence data.
- Tool: Foldseek - Ultra-fast structural search and clustering engine. View all tools →
- Tool: MMseqs2 - Fast and sensitive sequence search and clustering suite. View all tools →
- Event: Structural Biology Events (Open)
- Event: Protein Design Hub (LinkedIn Group) (Ongoing)
- Job: Assembly Biosciences, Inc. hiring Summer Intern, Bioinformatics and Data Science in South San Francisco, CA - LinkedIn at Bioinformatics Careers
- Job: Pinnacle Medicines hiring Director of Structural Biology in Doylestown, PA - LinkedIn at Bioinformatics Careers
Deep learning is not a magic wand, but a powerful lens for structural biology. — Recep Adiyaman